BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 272 filers reported holding BLUEBIRD BIO INC in Q4 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,288 | +44.1% | 423,733 | +56.0% | 0.01% | +71.4% |
| Q2 2023 | $894 | +20.8% | 271,627 | +154.0% | 0.01% | -36.4% |
| Q4 2022 | $740 | -100.0% | 106,923 | -56.0% | 0.01% | -45.0% |
| Q3 2022 | $1,539,000 | +115.2% | 243,095 | +40.7% | 0.02% | +122.2% |
| Q2 2022 | $715,000 | +114.1% | 172,759 | +150.7% | 0.01% | +125.0% |
| Q1 2022 | $334,000 | -78.7% | 68,909 | -16.1% | 0.00% | -81.0% |
| Q3 2021 | $1,570,000 | +259.3% | 82,133 | +913.7% | 0.02% | +133.3% |
| Q3 2020 | $437,000 | -68.3% | 8,102 | -64.1% | 0.01% | -75.0% |
| Q2 2020 | $1,379,000 | +241.3% | 22,585 | +413.3% | 0.04% | +157.1% |
| Q3 2019 | $404,000 | -13.9% | 4,400 | +19.4% | 0.01% | -26.3% |
| Q2 2019 | $469,000 | – | 3,686 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 5,910,687 | $24,470,000 | 3.71% |
| Monaco Asset Management SAM | 306,142 | $1,267,000 | 0.55% |
| Parametrica Management Ltd | 90,105 | $374,000 | 0.41% |
| Kamunting Street Capital Management, L.P. | 55,200 | $229,000 | 0.31% |
| Birchview Capital, LP | 98,000 | $406,000 | 0.30% |
| Kamunting Street Capital Management, L.P. | 35,000 | $145,000 | 0.20% |
| PDT Partners, LLC | 519,477 | $2,151,000 | 0.19% |
| Graham Capital Management, L.P. | 781,912 | $3,237,000 | 0.13% |
| CAXTON ASSOCIATES LP | 220,154 | $911,000 | 0.09% |
| Baker Brothers Advisors | 2,499,715 | $10,349,000 | 0.06% |